There is a strong and complex genetic component to multiple sclerosis (MS). In addition to variation in the major histocompatibility complex (MHC) region on chromosome 6p21.3, 110 non-MHC susceptibility variants have been identified in Northern Europeans, thus far. The majority of the MS-associated genes are immune related; however, similar to most other complex genetic diseases, the causal variants and biological processes underlying pathogenesis remain largely unknown. We created a comprehensive catalog of putative functional variants that reside within linkage disequilibrium regions of the MS-associated genic variants to guide future studies. Bioinformatics analyses were also conducted using publicly available resources to identify plausible pathological processes relevant to MS and functional hypotheses for established MS-associated variants.
INTRODUCTION
Multiple sclerosis (MS) is a clinically heterogeneous autoimmune disease of the central nervous system with a complex etiology, primarily characterized by demyelination and the formation of neurological lesions. 1 The prevalence of MS is greatest among Northern Europeans (0.1-0.2%). 1 There is a prominent genetic component illustrated by consistently higher disease concordance in monozygotic twins compared with dizygotic twins across several populations (30% and 5%, respectively), similar to other autoimmune diseases. 2 The relative recurrence risk (l s ) is B6.3 among siblings. 3 For several decades, variation within the major histocompatibility complex (MHC) on chromosome 6p21.3 has been known to confer the strongest genetic risk for MS. The primary susceptibility locus is a human leukocyte antigen (HLA) class II allele, HLA-DRB1*15:01.
1,4,5 Recent fine-mapping of the MHC demonstrated the presence of at least 10 additional independent HLA and non-HLA risk alleles for MS. 6 Full characterization of the non-MHC genetic component in MS has been challenging; however, 110 non-MHC risk variants have been identified within the last decade through both genome-wide association studies (GWASs) and follow-up candidate gene studies facilitated by international research initiatives (International Multiple Sclerosis Genetics Consortium and collaborative construction of the ImmunoChip). 4, 5 These variants explain 20% of l s , and with the inclusion of the four most prominent HLA risk alleles as much as 28% of l s . 5 These risk variants are both genic (63 single-nucleotide polymorphisms (SNPs) in 63 genes) and intergenic, similar to most complex diseases. For most of the 63 MS-associated genes, their contribution to pathogenesis is unclear; however, they appear to be primarily involved in immune response. In the largest MS association study, highresolution mapping was performed for 8 risk loci; for 5 of them, TNFSF14, IL2RA, TNFRSF1A, IL12A and STAT4, 50% of the posterior probability of association was explained by an intronic variant; 3 of the 5 variants are associated with protein levels. 5 Functional experiments have revealed the primary causal variants affecting protein structure through alternative splicing within IL7R 7 and TNFRSF1A. 8 However, the causal variants and the pathological biological processes mediated by the remaining 103 loci have not been fully explored.
Here, we present a comprehensive catalog of candidate functional variants within linkage disequilibrium (LD) blocks encompassing the non-MHC MS susceptibility loci to expedite the prioritization of SNPs for future fine-mapping analyses. We also conducted several bioinformatics enrichment analyses that integrated multiple functional (-omic) data for both MS-associated genes and the individual non-MHC risk variants. These results provide thorough insight into underlying disease mechanisms in MS based on current knowledge.
RESULTS

Of the 110 non-MHC MS risk variants, 63
SNPs are within genes, 1 SNP is within a noncoding RNA (PVT1) and the remaining 46 SNPs are intergenic (Table 1) . Using Haploreg v2 (2013.02.14; http://www.broadinstitute.org/mammals/haploreg/haploreg.php) 9 features of the genic risk SNPs were assessed. Among the genic risk SNPs, there were three missense SNPs (TYK2, SLC44A2 and IFI30), two 3 0 untranslated region (UTR) SNPs (EVI5 and CD69), one 5 0 UTR SNP (CD86), one synonymous SNP (TIMMDC1) and one downstream SNP (EOMES); the remaining 45 SNPs are intronic (Table 1) . With the exception of the TYK2 missense variant, these variants are fairly common with minor allele frequencies 45%. A total of 92 SNPs reside within regulatory motifs, and 27 SNPs reside within transcription factor binding sites. Interestingly, the MS risk variant rs4796791 is an intronic STAT3 (a transcription factor) SNP, and three other MS risk variants exist within signal transducer and activator of transcription 3 (STAT3) binding sites within their respective genes/noncoding RNA: rs4410871 (PVT1), rs917116 (JAZF1) and rs2236262 (ZFP36L1). Among all variants, there was a significant enrichment of strong enhancers for several cell lines, including human embryonic stem cells and leukemia Evi-1, FAC1, Foxa, Foxk1, Foxp1, HDAC2, Irf, Mef2, Nanog, Sox, TATA, Zfp105, p300
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To explore candidate functional variants within the 63 MS-associated genes, we cataloged all functional assignments (1000 Genomes release 13 December 2012 EBI; Supplementary Table 2) within the LD block boundaries containing the associated risk variant. LD blocks were constructed using the genotypes for Northern Europeans available in the 1000 Genomes Phase 3 integrated variant set (March 2012) 10 (see Materials and methods). To start, there were over 208 000 functional assignments within the 63 MS risk genes (Supplementary Table 3) ; when excluding intronic and noncoding transcript annotations, there were 81 311 functional assignments. Many SNPs possess multiple functional assignments because of transcript variation; for example, the TYK2 variant rs140324156 is annotated as synonymous, splice region, noncoding exon and 3 0 UTR variant (Supplementary Table 4 ). There were no LD blocks spanning the risk variants within CDH3, CXCR5 and MLANA ( Abbreviations: C, number of reference genes in the category; E, expected number in the category; GMCSF, granulocyte macrophage colony-stimulating factor; IL, interleukin; Jak, Janus kinase; KEGG, Kyoto Encyclopedia of Genes and Genomes; MHC, major histocompatibility complex; MS, multiple sclerosis; O, number of genes in the candidate gene list and within the category; PI3K, phosphatidylinositol 3-kinase; R, ratio of enrichment; SNP, single-nucleotide polymorphism; STAT, signal transducer and activator of transcription; TCR, T-cell receptor; VEGFR, vascular endothelial growth factor receptor.
There were functional variants within the LD block boundaries encompassing 43 risk SNPs; for 17 risk SNPs there were no functional variant variants within the LD block boundaries ( Table 2 ). The total number of functional assignments across these 43 genes was almost 116 000 annotations; when removing intronic and noncoding transcript annotations, there were 52 439 functional assignments (Figure 1a) . However, when focusing on variation within the LD blocks alone, there were 2816 unique SNPs (Supplementary Table 4 ) with 5244 functional assignments (Figure 1b) (Table 2) . Over 35% of all functional assignments were located within the 49.8-kb LD block encompassing TET2 rs2726518. There was a greater percentage of missense assignments among the 2816 unique SNPs (28%), compared with 21% among all assignments (not including intronic and noncoding transcript annotations). A similar increase was observed for 3 0 UTR assignments (10-18%) and frameshifts (3-5%), when comparing the 52 439 assignments across the 43 genes to the 5244 assignments within the 43 LD blocks (Figure 1) .
A major interest in human genetics is to distinguish missense polymorphisms that are functionally neutral from those that may contribute to disease. Using protein prediction algorithms, 816 missense variants were predicted to be 'deleterious' and/or 'probably damaging' for at least one gene transcript by SIFT (sorting intolerant from tolerant) 11 and PolyPhen (polymorphism phenotyping), 12 respectively, of which 373 missense variants were both 'deleterious' and 'probably damaging' (Supplementary Table 4 ; see Materials and methods). For the three missense MS risk variants, the predicted impact on protein function was: TYK2 rs34536443: 'deleterious' and 'probably damaging'; SLC44A2 rs2288904: 'tolerated' and 'benign'; and IFI30 rs11554159: 'deleterious' and 'possibly damaging'.
Functional classification of the 63 MS-associated genes was conducted using Web-based Gene Set Analysis Toolkit (WebGestalt; updated January 2013; http://bioinfo.vanderbilt. edu/webgestalt/), 13 and compared with all human genes, it suggests that there was an enrichment of several KEGG (Kyoto Encyclopedia of Genes and Genomes) pathways (Table 3) , including toxoplasmosis (P ¼ 2.6 Â 10 ), CD40/CD40L signaling (P ¼ 1.5 Â 10 À 7 ) and several pathways that shared a common gene set (P ¼ 1.5 Â 10 À 7 ; nectin adhesion, ErbB1 downstream, syndecan-1-mediated, vascular endothelial growth factor receptor 1/2-mediated, class I phosphatidylinositol 3-kinase and granulocyte macrophage colony-stimulating factormediated signaling pathways) were enriched among the MS genes (Table 3) . Using the Wiki Pathway database, genes involved in inflammatory response (P ¼ 5.9 Â 10 ) were overrepresented (Table 3) .
There was an enrichment of microRNA targets within the 63 MS-associated genes, including targets for miR-182, miR-524, miR-122A, miR-506, miR-29A, miR-29B, miR-29C, miR-181A, miR-181B, miR-181C, miR-181D and miR-124A (Po5 Â 10 À 3 ; Table 4 ). There were several transcription factor binding targets enriched among these genes; the most common were for NFAT, PAX4, Oct-1, NF-kB, Chx10, EST1, LEF1, Oct, ELK1 and AP-4 (Po5 Â 10 À 3 ; Table 4 ). Prednisone and immune globulins were among the drugs more strongly associated with these genes (Po5 Â 10 À 3 ; Table 4 ). Furthermore, there was an overrepresentation of several protein-protein interactions; the genes involved are largely reflective of the genes identified in enriched pathways (Table 4) .
DISCUSSION
Characterization of the genetic component of MS has greatly advanced within the past decade, primarily because of international efforts and the completion of recent GWASs followed by replication and meta-analyses. The primary genetic risk locus for MS is within the MHC, and recent efforts have finally begun to unravel the complexities within the region. 6 Thus far, 110 non-MHC disease-associated loci have been identified, although the functional pathological variants within these loci are largely unknown. 4, 5 We conducted a two-part bioinformatics analysis of these risk loci. First, all likely functional candidates within genes established through GWAS and follow-up studies were identified. Second, enrichment analyses were conducted to explore the underlying biology. Our results underscore the importance of cataloging likely functional candidates and assessing enrichment of various biological features as they relate to function and regulatory capacity of coding and noncoding variants.
GWASs are hypothesis free and do not provide any explicit biological evidence relating associated SNPs to disease; only a few SNPs per LD region are usually interrogated. As a result, it is unclear whether MS-associated SNPs are the causal variants; however, it is expected that the adjacent genomic regions in LD with the associated variant are likely to contain the biologically relevant polymorphisms.
14 Elucidating the causal variants within these susceptibility loci requires extensive functional experiments in conjunction with comprehensive fine-mapping analyses in larger association studies; both are time intensive and expensive. 15, 16 The utilization of bioinformatics resources to identify and prioritize candidate SNPs that may be phenotypically relevant is an efficient and cost-effective approach. Available bioinformatics tools can also reveal putative biological processes and pathways not previously known to contribute to pathogenicity. Until recently, determining functionality was largely restricted to nonsynonymous SNPs, and whether the encoded amino acid change was a neutral or deleterious substitution in the resulting protein. However, currently available resources can be used to interrogate a role for both genic and intergenic variations in protein regulation, expressivity and function. Furthermore, enrichment analyses can identify new experimental targets, including microRNA and transcription factor binding sites. Results from bioinformatics analyses presented here emphasize that many MS risk variants are not located within coding region of genes, and are likely to participate in gene regulation and expressivity. A total of 84% of the 110 established MS risk variants are located within a regulatory motif, and 25% are within a transcription factor binding site. The results also suggest complex interactions among MS risk genes, including STAT3 with PVT1, JAZF1 and ZFP36L1.
By focusing on variation within the LD block boundaries spanning 43 of the 63 genic MS risk SNPs, we identified 2816 SNPs as primary candidates for functional and fine-mapping investigations. Within these genes, there were 52 439 functional assignments; however, there was a 90% reduction in assignments when restricting to the LD blocks (5244 assignments). Within this catalog, 28% of these assignments were missense annotations; there were also 3 stop lost variants, 161 stop gain variants, 209 splice variants and 277 structural insertions, deletions and frameshifts. Based on these results, fine-mapping and functional studies can be focused; for example, MALT1 contains two missense SNPs within the LD block boundaries (Supplementary Table 4 ). The rs201310286 missense variant is rare (global minor allele frequency o0.001) and is predicted to be 'deleterious' (SIFT) and 'possibly damaging' (PolyPhen). MALT1 regulates the activation of nuclear factor (NF)-kB, a transcription factor for which binding targets are enriched among the MS-associated genes (Table 4) .
Results suggest the presence of a hierarchical biological relationship between MALT1 and other genes with NF-kB binding sites. In Malt1 À / À mice, T helper 17 cells demonstrated strong infiltration of the central nervous system. 17 Unfortunately, for 20 MS-associated genes there were either no LD blocks encompassing the risk variant (for example, CDH3, CXCR5 and MLANA) or there were no nonintronic/noncoding transcript assignments within the blocks (for example, the 332-bp block spanning ZMIZ1 rs1782645) ( Table 2 ). These 20 genic risk SNPs require further attention.
Several bioinformatics enrichment analyses were conducted in the current study. The primary biological mechanism highlighted by the 63 MS-associated genes is T-cell development, activation and signaling. We investigated three databases, each with very distinct unique pathways (number of pathways: KEGG ¼ 390; Pathway Commons ¼ 1651; WikiPathways ¼ 1018) and pathway names (Supplementary Table 5 ). Therefore, we utilized multiple databases for analysis and reviewed the genes identified within each enriched pathway. We observed common biological themes from among the enrichment pathways, for example, TCR signaling in KEGG (genes: MAPK1, CBLB and MALT1) and TCR signaling in CD 8 þ T cells in Pathway Commons (genes: IL2RA, EOMES, MAPK1, CD86, STAT4, TNFRSF1A and MALT1). Across the three pathway databases, TCR signaling processes were enriched. Similarly, the transcription factors overrepresented among the binding targets are also involved in T-cell development (nuclear factor of activated T-cells (NFAT) 18 ) and activation (NF-kB 17 ). Furthermore, there was an enrichment of microRNA targets for several microRNAs involved in T-cell clonal expansion (miR182), activation (miR181a) and differentiation (miR29). 19, 20 These results also encourage the exploration of other candidate genes with similar transcription factor and microRNA binding targets.
Interestingly, the enrichment analyses suggest an overlap between MS-associated genes and genes contributing to susceptibility for toxoplasmosis and cancer. Toxoplasmosis is a leading cause of death attributable to food-borne illnesses in the United States, but most infected individuals are asymptomatic (www.cdc.gov). A comparison of MS patients with (N ¼ 12) and without (N ¼ 12) toxoplasmosis suggest that infected cases had a less severe disease progression, determined by number of relapses and disability measures, and may be related to increased secretion of IL-10 and transforming growth factor-b and the presence of CD25 þ CD4 þ FoxP36 þ T cells. 21 A recent nationwide population-based cohort study in Taiwan observed an increased risk of developing cancer (85%) among MS cases, particularly breast cancer (2.2-fold increased risk). 22 These results complement prior bioinformatics analyses of non-MHC MS risk variants. Gene Ontology assessment of genes near the 52 risk variants identified in 2011 and of the 110 risk variants identified in 2013 suggested that processes involved T-cell differentiation were overrepresented. 4, 5 A protein-interactionnetwork-based pathway analysis of 137 457 SNPs that were nonsynonymous and potential deleterious (PolyPhen), located in 5 0 or 3 0 UTRs, or within transcription factor or histone binding sites in two large genetic MS studies demonstrated that encoded proteins are more likely to be connected within the proteininteraction-network, than by chance alone. 22 Based on analyses of 79 nominally significant genes within these two data sets, there was an overrepresentation of genes involved in leukocyte activation, apoptosis and positive regulation of macromolecule metabolic process, JAK-STAT signaling, acute myeloid leukemia and TCR signaling using Gene Ontology and KEGG pathways databases. 23 Our bioinformatics and enrichment analyses differ in approach; however, similar immunological processes were highlighted across all enrichment analyses.
Functional variants are likely to be adjacent to the GWAS signal, existing within LD blocks encompassing the risk SNPs. However, regions of strong LD can be large and SNPs associated with a phenotype can be in perfect LD with SNPs several hundred kilobases away. 14 We utilized LD block boundaries as defined by Gabriel et al. 24 and based on data from 279 Northern Europeans. Haplotype blocks inferred by different algorithms are likely to differ in size and coverage given SNP density and allele frequency distributions; however, shared chromosomal regions can increase with higher SNP density and the inclusion of less common variants. 25 In summary, we present the first comprehensive catalog of functional candidates for MS to expedite prioritization of SNP selection for fine-mapping and molecular studies. Application of bioinformatics and computational tools provided insight into the underlying biological pathways and regulatory processes that may contribute to MS onset. The in silico methods employed can be adapted by any investigator to a priori SNP selection or post hoc evaluation of variants established through GWASs. Investigators must keep in mind that databases for bioinformatics analysis are not necessarily complete, and the algorithms employed by various tools may differ. Thus, we recommend the use of multiple bioinformatics tools and available resources. Our results emphasize a role for T-cell dysregulation in MS pathogenesis, and complex gene-gene interactions between STAT3 and PVT1, JAZF1 and ZFP36L1 and MALT1 and NF-kB target genes.
MATERIALS AND METHODS
Characterization of MS risk variants
The physical location and functional annotation for each of the 110 non-MHC risk variants were characterized using the Genome Reference Consortium GRCh37 (hg19) available in the UCSC Genome Browser 26 and Haploreg v2 (2013.02.14; http://www.broadinstitute.org/mammals/ haploreg/haploreg.php). 9 The regulatory capacity of all coding and noncoding variants was also assessed using Haploreg. Haploreg is a bioinformatics resource that includes an extensive library of SNPs (dbSNP 137), motif instances (including position weight matrices collected from TRANSFAC, JASPAR, protein-binding microarray,and ENCODE CHIPseq experiments), [27] [28] [29] [30] expression quantitative trait loci (GTex eQTL browser) 31 and enhancer annotation (Roadmap Epigenome Mapping Consortium). 32, 33 Allele frequencies are based on 1000 Genomes Phase 1 low-coverage data. 10 Haploreg also performs enhancer and DNase enrichment analyses using a binomial test, comparing the coverage of enhancers, strong enhancers and DNase sites of the query list of variants to all variants.
Identification of functional candidates within MS-associated genes
For the 63 genic risk SNPs, all variation within 50 kb upstream or downstream of each gene boundary was extracted from the 1000 Genomes Phase 3 integrated variant set (March 2012) . This data set is based on 1000 Genomes Project sequence data freezes from November 2010 (low-coverage whole-genome) and May 2011 (high-coverage exome) that was revised in February and March 2012 to remove sequencing artifacts for 1092 individuals (246 Africans, 181 Asians and 379 Europeans). 10 This autosomal variant set (36 648 992 SNPs; 1 380 736 INDELs; 13 805 structural variants) did not include sites that were monomorphic. LD blocks spanning the 63 genic risk SNPs were determined in 267 Northern Europeans (85 Utah residents with Northern and Western European ancestry, 93 Finnish in Finland and 80 British in England and Scotland). Blocks were constructed using the approach suggested by Gabriel et al., 24 as implemented in PLINK v1.07. 34 Functional annotation for all variants within the MS-associated genes was downloaded from the 1000 Genomes Browser (1000 Genomes release 13 December 2012, EBI). Information for variation was not restricted, and thus included annotation for variants for which there were no genotypic data in the phase 3 integrated variant set. We included all functional assignments (Supplementary Table 2 ) for each SNP; for example, SNPs within genes with multiple transcripts may also have varying function dependent on the transcript. We did not consider SNPs that were only intronic or noncoding transcript variants across all gene transcripts. For missense variants, impact on protein function based on in silico tools was also extracted. Predictive values from both SIFT 11 ('tolerated' to 'deleterious assignments') and PolyPhen 12 ('benign' to 'probably damaging assignments') determined the potential pathogenicity of missense variants. SIFT values of p0.05 are considered 'deleterious', and PolyPhen values of 40.905 are 'probably damaging'. We subsequently extracted all functional annotation within the LD block boundaries for the 63 genic MS risk SNPs.
Bioinformatics enrichment analyses of MS-associated genes
Comprehensive bioinformatics analyses for the 63 MS-associated genes were conducted using Web-based Gene Set Analysis Toolkit (WebGestalt; updated January 2013; http://bioinfo.vanderbilt.edu/webgestalt/) that incorporates publicly available biological and functional data for enrichment analysis. 13 It includes several unique features compared with other bioinformatic tools (Supplementary Table 6 ). 35 41 updated 26 January 2013). Enrichment analyses were conducted using hygergeometric tests. P-values were corrected for multiple testing based on the false discovery rate using the Benjamini and Hochberg procedure. 13 We considered all human genes as the appropriate reference for comparison. The top 10 enriched classes for each bioinformatics analysis were reported.
